Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck
dc.creator | García-Pedrero J.M. | |
dc.creator | Martínez-Camblor P. | |
dc.creator | Diaz-Coto S. | |
dc.creator | Munguia-Calzada P. | |
dc.creator | Vallina-Alvarez A. | |
dc.creator | Vazquez-Lopez F. | |
dc.creator | Rodrigo J.P. | |
dc.creator | Santos-Juanes J. | |
dc.date.accessioned | 2020-09-02T22:18:51Z | |
dc.date.accessioned | 2022-11-08T20:22:29Z | |
dc.date.available | 2020-09-02T22:18:51Z | |
dc.date.available | 2022-11-08T20:22:29Z | |
dc.date.created | 2020-09-02T22:18:51Z | |
dc.date.issued | 2017 | |
dc.identifier | 77, 3, 527-533 | |
dc.identifier | 01909622 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4639 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144438 | |
dc.language | en | |
dc.publisher | Mosby Inc. | |
dc.subject | cutaneous squamous cell carcinoma | |
dc.subject | expression | |
dc.subject | immunohistochemistry | |
dc.subject | nodal metastasis | |
dc.subject | PD-L1 | |
dc.subject | prognosis | |
dc.subject | tumor | |
dc.subject | programmed death 1 ligand 1 | |
dc.subject | programmed death 1 ligand 1 | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | cancer patient | |
dc.subject | cancer prognosis | |
dc.subject | cancer staging | |
dc.subject | cancer survival | |
dc.subject | clinical feature | |
dc.subject | controlled study | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | head and neck carcinoma | |
dc.subject | histopathology | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | lymph node metastasis | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | overall survival | |
dc.subject | priority journal | |
dc.subject | protein expression | |
dc.subject | retrospective study | |
dc.subject | risk factor | |
dc.subject | skin carcinoma | |
dc.subject | T lymphocyte activation | |
dc.subject | tissue microarray | |
dc.subject | tumor differentiation | |
dc.subject | tumor growth | |
dc.subject | tumor volume | |
dc.subject | wide excision | |
dc.subject | biosynthesis | |
dc.subject | head and neck tumor | |
dc.subject | lymph node metastasis | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | secondary | |
dc.subject | skin tumor | |
dc.subject | squamous cell carcinoma | |
dc.subject | very elderly | |
dc.subject | Aged | |
dc.subject | Aged, 80 and over | |
dc.subject | Antigens, CD274 | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Female | |
dc.subject | Head and Neck Neoplasms | |
dc.subject | Humans | |
dc.subject | Lymphatic Metastasis | |
dc.subject | Male | |
dc.subject | Retrospective Studies | |
dc.subject | Skin Neoplasms | |
dc.title | Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck | |
dc.type | Article |